dexamethasone,carfilzomib,bortezomib,elotuzumab,drd,pomalidomide,ixazomib,panobinostat,selinexor,daratumumab,lenalidomide,Isatuximab,Elotuzumab
amgen,sanofi,akynzeo,karyopharm,bms,secura bio,janssen,takeda,janssen 
['daratumumab', 'ixazomib', ' lena', 'castor', 'mmsm', 'optimismm', 'ikema', 'pollux', 'lenalidomide', 'candor', 'krd', 'pomalidomide', 'bortezomib', 'dexamethasone', 'borte', 'elotuzumab', 'panobinostat', 'carfilzomib', 'selinexor']
#ash22 #mmsm education session
dr. freeman: fitness and frailty in myeloma breakdown of regimen options in relapsed setting with focus on frail/older pts 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities